Mutational study of p16CDKN2/MTS1/INK4A and p57KIP2 genes in hepatocellular carcinoma

F Bonilla1, I Orlow, C Cordón-Cardó

  • 1Molecular Genetics Unit, Clinica del Trabajo, Avd. de la Reina Victoria, 21, Madrid, 28003, Spain.

Insights

Alterations in p16 and p57KIP2 genes are uncommon in hepatocellular carcinoma (HCC). However, microsatellite alterations in the 9p21-24 region were observed in 24% of HCC cases studied.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • p16 and p15 are key cyclin-dependent kinase inhibitors.
  • p57KIP2 exhibits selective expression in the liver.
  • p16CDKN2/MTS1/INK4A alterations are frequent in various primary tumors.

Purpose of the Study:

  • To investigate alterations in p16 and p57KIP2 genes in hepatocellular carcinoma (HCC).
  • To determine the frequency of genetic changes in these tumor suppressor genes within HCC.

Main Methods:

  • Analysis of 17 tumor and normal DNA pairs from HCC patients.
  • Utilized Southern blot, PCR-SSCP, and DNA sequencing.
  • Employed microsatellite markers for the p16 gene region (9p21-24).

Main Results:

  • Southern blot analysis revealed no allelic losses for p16 or p57KIP2.
  • An additional band was detected with p16 cDNA in 4 out of 17 cases.
  • Microsatellite alterations in the 9p21-24 region were found in 4/17 (24%) of HCC cases.

Conclusions:

  • Deletions or point mutations in p16 and p57KIP2 are infrequent in HCC.
  • The study identified microsatellite alterations in the 9p21-24 region in a subset of HCC.
  • Further research may clarify the role of these microsatellite alterations in HCC pathogenesis.